Last edition
News about "Licensing Deal "
Kaigene Licenses Autoimmune Drug KG006 to Taisho Pharma in Japan
Taisho Pharmaceutical secures exclusive rights to clinically develop, register, and commercialise Kaigene's next-generation FcRn inhibitor, KG006, in Japan.
Licensing Deal | 01/08/2026 | By News Bureau
Mabwell Signs Malaysia Deal for Denosumab Biosimilars
Mabwell signs a Malaysia licensing deal for denosumab biosimilars, with its partner leading registration and commercialisation while Mabwell handles development, production and supply, strengthening its Asia market expansion strategy.
Licensing Deal | 20/04/2026 | By News Bureau | 110
Zydus and Torrent Pharma Sign Licensing Deal to Co-Market Semaglutide in India
Zydus Lifesciences and Torrent Pharmaceuticals have entered a licensing agreement to co-market Semaglutide injection in India, aiming to improve access for patients with poorly controlled Type 2 Diabetes Mellitus and support chronic weight management through advanced, innovative therapy.
Licensing Deal | 19/03/2026 | By News Bureau | 231
Formosa Pharma Signs Licensing Deal with DAVI for Clobetasol Propionate Ophthalmic Suspension
The DÁVI licensing agreement includes upfront, commercialization milestones, and sales milestones, with additional considerations throughout the term of the agreement.
Licensing Deal | 04/11/2024 | By Aishwarya | 721
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy